| 1 | DVBCWEM1 ;ALB/CMM ENDOCRINE MISC. DISEASES WKS TEXT - 1 ; 5 MARCH 1997
 | 
|---|
| 2 |  ;;2.7;AMIE;**12**;Apr 10, 1995
 | 
|---|
| 3 |  ;
 | 
|---|
| 4 |  ;
 | 
|---|
| 5 | TXT ;
 | 
|---|
| 6 |  ;;A.  Review of Medical Records:
 | 
|---|
| 7 |  ;;
 | 
|---|
| 8 |  ;;
 | 
|---|
| 9 |  ;;
 | 
|---|
| 10 |  ;;B.  Medical History (Subjective Complaints):
 | 
|---|
| 11 |  ;;
 | 
|---|
| 12 |  ;;     Comment on:
 | 
|---|
| 13 |  ;;     1.  Date of diagnosis and how established.
 | 
|---|
| 14 |  ;;
 | 
|---|
| 15 |  ;;
 | 
|---|
| 16 |  ;;     2.  Fatigability.
 | 
|---|
| 17 |  ;;
 | 
|---|
| 18 |  ;;
 | 
|---|
| 19 |  ;;     3.  Headaches.
 | 
|---|
| 20 |  ;;
 | 
|---|
| 21 |  ;;
 | 
|---|
| 22 |  ;;     4.  Changes in vision.
 | 
|---|
| 23 |  ;;
 | 
|---|
| 24 |  ;;
 | 
|---|
| 25 |  ;;     5.  Neurologic, cardiovascular, or gastrointestinal symptoms.
 | 
|---|
| 26 |  ;;
 | 
|---|
| 27 |  ;;
 | 
|---|
| 28 |  ;;     6.  Treatments (surgery, medications, hormones), including dose,
 | 
|---|
| 29 |  ;;         frequency, response, side effects.  For malignancy, provide 
 | 
|---|
| 30 |  ;;         date of completion of treatment for malignancy.
 | 
|---|
| 31 |  ;;
 | 
|---|
| 32 |  ;;
 | 
|---|
| 33 |  ;;     7.  Weight gain or loss.
 | 
|---|
| 34 |  ;;
 | 
|---|
| 35 |  ;;
 | 
|---|
| 36 |  ;;     8.  Excessive thirst, frequency of urination.  
 | 
|---|
| 37 |  ;;
 | 
|---|
| 38 |  ;;
 | 
|---|
| 39 |  ;;     9.  Describe the effects of the condition(s) on the veteran's 
 | 
|---|
| 40 |  ;;         usual occupation and daily activities.
 | 
|---|
| 41 |  ;;
 | 
|---|
| 42 |  ;;
 | 
|---|
| 43 |  ;;C.  Physical Examination (Objective Findings):
 | 
|---|
| 44 |  ;;
 | 
|---|
| 45 |  ;;    Address each of the following and fully describe current findings:
 | 
|---|
| 46 |  ;;    1.  For hypoparathyroidism, thyroid surgery scar?
 | 
|---|
| 47 |  ;;
 | 
|---|
| 48 |  ;;
 | 
|---|
| 49 |  ;;    2.  For diabetes insipidus, signs of dehydration?
 | 
|---|
| 50 |  ;;
 | 
|---|
| 51 |  ;;
 | 
|---|
| 52 |  ;;    3.  For Addison's disease, muscle strength, blood pressure, skin 
 | 
|---|
| 53 |  ;;        pigmentary changes.  Number of crises (with peripheral vascular 
 | 
|---|
| 54 |  ;;        collapse) or episodes (less acute and severe than crisis - no
 | 
|---|
| 55 |  ;;        peripheral vascular collapse).
 | 
|---|
| 56 |  ;;
 | 
|---|
| 57 |  ;;
 | 
|---|
| 58 |  ;;    4.  For pluriglandular syndromes, see examinations for glands affected.
 | 
|---|
| 59 |  ;;
 | 
|---|
| 60 |  ;;
 | 
|---|
| 61 |  ;;    5.  Describe all residuals of benign or malignant neoplasm, 
 | 
|---|
| 62 |  ;;        including those related to treatment.
 | 
|---|
| 63 |  ;;
 | 
|---|
| 64 |  ;;
 | 
|---|
| 65 |  ;;    6.  Is the disease active or in remission?
 | 
|---|
| 66 |  ;;
 | 
|---|
| 67 |  ;;
 | 
|---|
| 68 |  ;;    7.  For hyperparathyroidism, history of kidney stones.  History 
 | 
|---|
| 69 |  ;;        demineralization of skeleton.
 | 
|---|
| 70 |  ;;
 | 
|---|
| 71 |  ;;
 | 
|---|
| 72 |  ;;D.  Diagnostic and Clinical Tests:
 | 
|---|
| 73 |  ;;
 | 
|---|
| 74 |  ;;    Provide, as appropriate/as needed to establish diagnosis:
 | 
|---|
| 75 |  ;;    1.  Blood and urinary calcium.
 | 
|---|
| 76 |  ;;    2.  X-ray of bones to confirm decalcification.
 | 
|---|
| 77 |  ;;    3.  Glucose tolerance test, if necessary.
 | 
|---|
| 78 |  ;;    4.  Antidiuretic hormone level.
 | 
|---|
| 79 |  ;;    5.  Serum and urine electrolytes.
 | 
|---|
| 80 |  ;;    6.  Urine specific gravity.
 | 
|---|
| 81 |  ;;    7.  Serum cortisol.
 | 
|---|
| 82 |  ;;    8.  Serum creatinine.
 | 
|---|
| 83 |  ;;    9.  Serum glucose.
 | 
|---|
| 84 |  ;;   10.  ACTH test.
 | 
|---|
| 85 |  ;;   11.  Include results of all diagnostic and clinical tests conducted
 | 
|---|
| 86 |  ;;        in the examination report.
 | 
|---|
| 87 |  ;;
 | 
|---|
| 88 |  ;;
 | 
|---|
| 89 |  ;;
 | 
|---|
| 90 |  ;;E.  Diagnosis:
 | 
|---|
| 91 |  ;;
 | 
|---|
| 92 |  ;;
 | 
|---|
| 93 |  ;;Signature:                             Date:
 | 
|---|
| 94 |  ;;END
 | 
|---|